Innate antiviral resistance influences the efficacy of a recombinant murine cytomegalovirus immunocontraceptive vaccine

Vaccine

Volumn 25, Issue 4, 2007, Pages 679-690

  Lloyd, Megan L ^a   Nikolovski, Sonia ^a   Lawson, Malcolm A ^a   Shellam, Geoffrey R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Immunocontraception; Murine cytomegalovirus; Recombinant vaccine; Zona pellucida

Indexed keywords

CONTRACEPTIVE VACCINE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; VIRUS VECTOR; ZONA PELLUCIDA 3 ANTIGEN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG SALIVA LEVEL; EXPRESSION VECTOR; FEMALE; FEMALE FERTILITY; FEMALE STERILITY; GENE LOCUS; HAPLOTYPE; IMMUNOCONTRACEPTION; INBRED STRAIN; INNATE IMMUNITY; LUNG; MALE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; OBSERVATION; OUTBRED STRAIN; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS RESISTANCE; WILD TYPE; ZONA PELLUCIDA;

ANIMALS; CONTRACEPTION, IMMUNOLOGIC; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EGG PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, NATURAL; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; PREGNANCY; RECEPTORS, CELL SURFACE;

EID: 33845291149     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.08.019     Document Type: Article

References (37)

1. Kurz S., Steffens H.P., Mayer A., Harris J.R., and Reddehase M.J. Latency versus persistence or intermittent recurrences-evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71 4 (1997) 2980-2987
2. Pollock J.L., and Virgin H.W. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol 69 3 (1995) 1762-1768
3. Henry S.C., Schmader K., Brown T.T., Miller S.E., Howell D.N., Daley G.G., and Hamilton J.D. Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J Virol Methods 89 1-2 (2000) 61-73
4. Brune W., Hasan M., Krych M., Bubic I., Jonjic S., and Koszinowski U.H. Secreted virus-encoded proteins reflect murine cytomegalovirus productivity in organs. J Infect Dis 184 10 (2001) 1320-1324
5. Lagenaur L.A., Manning W.C., Vieira J., Martens C.L., and Mocarski E.S. Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J Virol 68 12 (1994) 7717-7727
6. Latchman D.S. Gene delivery and gene therapy with herpes simplex virus-based vectors. Gene 264 1 (2001) 1-9
7. Shellam G.R. The potential of murine cytomegalovirus as a viral vector for immunocontraception. Reprod Fertil Dev 6 3 (1994) 401-409
8. Lloyd M.L., Shellam G.R., Papadimitriou J.M., and Lawson M.A. Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3. Biol Reprod 68 6 (2003) 2024-2032
9. 8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol 78 5 (2004) 2255-2264
10. Grundy J.E., Mackenzie J.S., and Stanley N.F. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun 32 1 (1981) 277-286
11. Allan J.E., and Shellam G.R. Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch Virol 81 1-2 (1984) 139-150
12. Lawson C.M., Grundy J.E., and Shellam G.R. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J Gen Virol 69 Pt 8 (1988) 1987-1998
13. Scalzo A.A., Fitzgerald N.A., Simmons A., La Vista A.B., and Shellam G.R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171 (1990) 1469-1483
14. Scalzo A.A., Fitzgerald N.A., Wallace C.R., Gibbons A.E., Smart Y.C., Burton R.C., and Shellam G.R. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149 2 (1992) 581-589
15. Brown M.G., Scalzo A.A., Stone L.R., Clark P.Y., Du Y., Palanca B., and Yokoyama W.M. Natural killer gene complex (Nkc) allelic variability in inbred mice: evidence for Nkc haplotypes. Immunogenetics 53 7 (2001) 584-591
16. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., and Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 194 1 (2001) 29-44
17. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 28 1 (2001) 42-45
18. Singleton G.R., Farroway L.N., Chambers L.K., Lawson M.A., Smith A.L., and Hinds L.A. Ecological basis for fertility control in the house mouse (Mus domesticus) using immunocontraceptive vaccines. Reproduction Suppl. 60 (2002) 31-39
19. Scalzo A.A., Manzur M., Forbes C.A., Brown M.G., and Shellam G.R. NK gene complex haplotype variability and host resistance alleles to murine cytomegalovirus in wild mouse populations. Immunol Cell Biol 83 2 (2005) 144-149
20. Poiley S.M. A systematic method of breeder rotation for non-inbred laboratory animal colonies. Proc Anim Care Panel 10 4 (1960) 159-166
21. Scalzo A.A., Brown M.G., Chu D.T., Heusel J.W., Yokoyama W.M., and Forbes C.A. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics 49 3 (1999) 238-241
22. Saederup N., Lin Y.C., Dairaghi D.J., Schall T.J., and Mocarski E.S. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci USA 96 19 (1999) 10881-10886
23. Sambrook J., Fritch E., and Maniatis T. Molecular cloning: a laboratory manual (1989), Cold Spring Harbor Laboratory Press, New York
24. Gorman S., Harvey N.L., Moro D., Lloyd M.L., Voigt V., Smith L.M., et al. Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice. J Gen Virol 87 (2006) 1123-1132
25. Wheat R.L., Clark P.Y., and Brown M.G. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. J Virol Methods 112 1-2 (2003) 107-113
26. Karupiah G., Sacks T.E., Klinman D.M., Fredrickson T.N., Hartley J.W., Chen J.H., and Morse H.C. Murine cytomegalovirus infection-induced polyclonal b cell activation is independent of cd4(+) t cells and cd40. Virology 240 1 (1998) 12-26
27. Price P., Olver S.D., Gibbons A.E., and Shellam G.R. B-cell activation following murine cytomegalovirus infection: implications for autoimmunity. Immunology 78 1 (1993) 14-21
28. Bubic I., Wagner M., Krmpotic A., Saulig T., Kim S., Yokoyama W.M., et al. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78 14 (2004) 7536-7544
29. Voigt V., Forbes C.A., Tonkin J.N., Degli-Esposti M.A., Smith H.R., Yokoyama W.M., and Scalzo A.A. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA 100 23 (2003) 13483-13488
30. Scalzo A.A., Lyons P.A., Fitzgerald N.A., Forbes C.A., Yokoyama W.M., and Shellam G.R. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics 27 3 (1995) 435-441
31. k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol 175 (2005) 6820-6828
32. Desrosiers M.P., Kielczewska A., Loredo-Osti J.C., Adam S.G., Makrigiannis A.P., Lemieux S., et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 37 6 (2005) 593-599
33. Redwood A.J., Messerle M., Harvey N.L., Hardy C.M., Koszinowski U.H., Lawson M.A., and Shellam G.R. Use of a murine cytomegalovirus k181-derived bacterial artificial chromosome as a vaccine vector for Immunocontraception. J Virol 79 5 (2005) 2998-3008
34. Fayrer-Hosken R.A., Bertschinger H.J., Kirkpatrick J.F., Grobler D., Lamberski N., Honneyman G., and Ulrich T. Contraceptive potential of the porcine zona pellucida vaccine in the African elephant (Loxodonta africana). Theriogenology 52 5 (1999) 835-846
35. Garrott R.A., Cook J.G., Bernoco M.M., Kirkpatrick J.F., Cadwell L.L., Cherry S., and Tiller B. Antibody response of elk immunized with porcine zona pellucida. J Wildl Dis 34 3 (1998) 539-546
36. Hardy C.M., Clydesdale G., and Mobbs K.J. Development of mouse-specific contraceptive vaccines: infertility in mice immunized with peptide and polyepitope antigens. Reproduction 128 4 (2004) 395-407
37. Farrell H.E., and Shellam G.R. Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice. J Gen Virol 70 Pt 10 (1989) 2573-2586